Author： Geuna Elena Milani Andrea Redana Stefania Rossi Valentina Valabrega Giorgio Aglietta Massimo Montemurro Filippo
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.4, 2011-03, pp. : 549-565
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HER2-Positive Breast Cancer: Current and Future Treatment Strategies
By Engel Ryan H. Kaklamani Virginia G.
Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. :
Access to resources
Recommend
Trastuzumab: In HER2 and Hormone Receptor Co-Positive Metastatic Breast Cancer
By Orman Jennifer S. Perry Caroline M.
Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. :
Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. :